News

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...
Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...
H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...
Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...
HBAR could recover above $0.25 amid SWIFT blockchain trials, but the current market correction could affect its comeback.
The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...
More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...
New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small ...
Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers (ACCC), sat down for an interview with CURE to discuss the need for ...
SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...